BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17724441)

  • 1. Association of squamous cell carcinoma of the oral cavity in allogeneic hematopoietic stem cell transplant recipients.
    Reddy NM; Sullivan MA; Hahn TE; Battiwalla M; Smiley SL; McCarthy PL
    Bone Marrow Transplant; 2007 Nov; 40(9):907-9. PubMed ID: 17724441
    [No Abstract]   [Full Text] [Related]  

  • 2. A case report of secondary oral squamous cell carcinoma after allogeneic hematopoietic stem cell transplantation.
    Liu Z; Peng Y; Yong X; Mei G; Yang Y; Yi C; Tao R
    Oral Oncol; 2020 Oct; 109():104629. PubMed ID: 32165139
    [No Abstract]   [Full Text] [Related]  

  • 3. Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation.
    Schimmelpfennig C; Naumann R; Zuberbier T; Ordemann R; Baurmann H; Beyer J; Siegert W; Bornhäuser M; Ehninger G
    Bone Marrow Transplant; 2001 Apr; 27(7):753-5. PubMed ID: 11360117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes.
    Mawardi H; Elad S; Correa ME; Stevenson K; Woo SB; Almazrooa S; Haddad R; Antin JH; Soiffer R; Treister N
    Bone Marrow Transplant; 2011 Jun; 46(6):884-91. PubMed ID: 21460866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late effects after autologous hematopoietic cell transplantation.
    Burns LJ
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):21-4. PubMed ID: 19147072
    [No Abstract]   [Full Text] [Related]  

  • 6. Squamous cell carcinoma of the buccal mucosa in a young adult with history of allogeneic bone marrow transplantation for childhood acute leukemia.
    Tomihara K; Dehari H; Yamaguchi A; Abe M; Miyazaki A; Nakamori K; Hareyama M; Hiratsuka H
    Head Neck; 2009 Apr; 31(4):565-8. PubMed ID: 18972418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor bone marrow-derived stem cells contribute to oral squamous cell carcinoma transformation in a recipient after hematopoietic stem cell transplantation.
    Hu YX; Luo Y; Tan YM; Shi JM; Sheng LX; Fu HR; Liu LZ; Xu YL; Wu KN; Xiao HW; Zhang LF; Yu XH; Cai Z; Huang H
    Stem Cells Dev; 2012 Jan; 21(2):177-80. PubMed ID: 21910644
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased mean corpuscular volume after autologous hematopoietic stem cell transplantation: incidence and significance.
    Kamble RT; Hamadani M; Selby GB
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):111-2. PubMed ID: 16399575
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary cancers following allogeneic haematopoietic cell transplantation in adults.
    Majhail NS
    Br J Haematol; 2011 Aug; 154(3):301-10. PubMed ID: 21615719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HB vaccination in the prevention of viral reactivation in allogeneic hematopoietic stem cell transplantation recipients with previous HBV infection.
    Onozawa M; Hashino S; Darmanin S; Okada K; Morita R; Takahata M; Shigematsu A; Kahata K; Kondo T; Tanaka J; Imamura M; Asaka M
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1226-30. PubMed ID: 18940676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fatigue in hematological patients treated with allogeneic stem cell transplantation].
    Kalo J; Agergård J; Aadahl M; Visby R; Kristensen JH; Jacobsen N
    Ugeskr Laeger; 2007 Sep; 169(38):3194-7. PubMed ID: 17910829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting survival in adults with invasive aspergillosis during therapy for hematological malignancies or after hematopoietic stem cell transplantation: Single-center analysis and validation of the Seattle, French, and Strasbourg prognostic indexes.
    Parody R; Martino R; Sánchez F; Subirá M; Hidalgo A; Sierra J
    Am J Hematol; 2009 Sep; 84(9):571-8. PubMed ID: 19676118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Squamous cell carcinoma of the oral cavity following breast cancer treatment.
    Ye G; Burton GV; Nathan CO; Ampil FL
    South Med J; 2006 Oct; 99(10):1150-1. PubMed ID: 17100048
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of gonadal damage in recipients of allogeneic or autologous transplantation for haematological malignancies.
    Chatterjee R; Kottaridis PD
    Bone Marrow Transplant; 2002 Nov; 30(10):629-35. PubMed ID: 12420200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Kataoka K; Nannya Y; Hangaishi A; Imai Y; Chiba S; Takahashi T; Kurokawa M
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):195-204. PubMed ID: 19167679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
    Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Invasive fungous infections in post haematopoietic stem cell transplant patients--editorial].
    Cetkovský P
    Vnitr Lek; 2007 Sep; 53(9):931-3. PubMed ID: 18019659
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Michallet M; Le QH; Mohty M; Prébet T; Nicolini F; Boiron JM; Esperou H; Attal M; Milpied N; Lioure B; Bordigoni P; Yakoub-Agha I; Bourhis JH; Rio B; Deconinck E; Renaud M; Chir Z; Blaise D
    Exp Hematol; 2008 May; 36(5):535-44. PubMed ID: 18346838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.